Papers: 23 Aug 2013 - 30 Aug 2013
IL7RA haplotype-associated alterations in cellular immune function and gene expression patterns in multiple sclerosis.
[Assessment of the influence of rehabilitation in patients treated in a hospital rehabilitation ward due to consequences of neurological diseases].
Review series on immune responses in neurodegenerative diseases: Oligodendrocyte-microglia cross-talk in the CNS.
Antiparasitic antibodies occur with similar frequency in patients with clinically established multiple sclerosis with or without oligoclonal bands in the cerebrospinal fluid.
Medication withdrawal may be an option for a select group of patients in relapsing-remitting multiple sclerosis.
Home-based exercise program and fall-risk reduction in older adults with multiple sclerosis: phase 1 randomized controlled trial.
Sex-specific extent and severity of white matter damage in multiple sclerosis: Implications for cognitive decline.
Walking execution is not affected by divided attention in patients with multiple sclerosis with no disability, but there is a motor planning impairment.
Therapeutic Effect of Transplanted Human Wharton's Jelly Stem Cell-Derived Oligodendrocyte Progenitor Cells (hWJ-MSC-derived OPCs) in an Animal Model of Multiple Sclerosis.
Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).
Demyelinating encephalopathy in adult onset Still's disease: Case report and review of the literatures.
Parasite Infections in Multiple Sclerosis Modulate Immune Responses through a Retinoic Acid-Dependent Pathway.
Nonlinear dynamical structure of sway path during standing in patients with multiple sclerosis and in healthy controls is affected by changes in sensory input and cognitive load.
Evaluation of plaque detection and optimum time of enhancement in acute attack multiple sclerosis after contrast injection.
Resting-state functional connectivity in multiple sclerosis: An examination of group differences and individual differences.
Comparison of in vivo immunomodulatory effects of intravenous and intraperitoneal administration of adipose-tissue mesenchymal stem cells in experimental autoimmune encephalomyelitis (EAE).
Oral BG-12 (dimethyl fumarate) for relapsing-remitting multiple sclerosis: a review of DEFINE and CONFIRM Evaluation of: Gold R, Kappos L, Arnold D, et al. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med 2012;
Dose-related effects of vitamin D on immune responses in patients with clinically isolated syndrome and healthy control participants: study protocol for an exploratory randomized double- blind placebo-controlled trial.
Anti-JCV Antibodies Detection and JCV DNA Levels in PBMC, Serum and Urine in a Cohort of Spanish Multiple Sclerosis Patients Treated with Natalizumab.
A standardized motor imagery introduction program (MIIP) for neuro-rehabilitation: development and evaluation.
Tremor reduction and quality of life after deep brain stimulation for multiple sclerosis-associated tremor.
Induction of Encephalitis in Rhesus Monkeys Infused with Lymphocryptovirus-Infected B-Cells Presenting MOG34-56 Peptide.
Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications.
The effect of fluoxetine on progression in progressive multiple sclerosis: a double-blind, randomized, placebo-controlled trial.